http://purl.org/np/RAUYWltYQF... RAUYWltYQF

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

Leoni Bücken

2021-07-03T13:57:24.084Z

http://purl.org/np/RAUYWltYQF... RAUYWltYQF

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

ilaris is an interleukin 1b blocker indicated for the treatment of periodic fever syndromes cryopyrin associated periodi c syndromes caps familial cold autoinflammatory syndrome fcas 1 1 muckle wells syndrome mws 1 1 tumor necrosis factor receptor associated periodic syndrome traps 1 1 hyperimmunoglobulin d syndrome hids mevalonate kinase deficiency mkd 1 1 familial mediterranean fever fmf 1 1 active systemic juvenile idiopathic arthritis sjia 1 2 ilaris r cryopyrin associated periodic syndromes caps ilaris is indicated for the treatment of cryopyrin associated periodic syndromes caps in adults and children 4 years of age and older including familial cold autoinflammatory syndrome fcas muckle wells syndrome mws tumor necrosis factor receptor tnf associated periodic syndrome traps ilaris is indicated for the treatment of tumor necrosis factor tnf receptor associated periodic syndrome traps in adult and pediatric patients hyperimmunoglobulin d syndrome hids mevalonate kinase deficiency mkd ilaris is indicated for the treatment of hyperimmunoglobulin d hyper igd syndrome hids mevalonate kinase deficiency mkd in adult and pediatric patients familial mediterranean fever fmf ilaris is indicated for the treatment of familial mediterranean fever fmf in adult and pediatric patients ilaris is indicated for the treatment of active systemic juvenile idiopathic arthritis sjia in patients aged 2 years and older

Leoni Bücken

2021-07-03T13:57:24.084Z

http://purl.org/np/RAUYWltYQF... RAUYWltYQF

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/DOID_0050452 DOID_0050452

Leoni Bücken

2021-07-03T13:57:24.084Z

http://purl.org/np/RAUYWltYQF... RAUYWltYQF

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Leoni Bücken

2021-07-03T13:57:24.084Z

http://purl.org/np/RAUYWltYQF... RAUYWltYQF

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/drugbank:DB06168 drugbank:DB06168

Leoni Bücken

2021-07-03T13:57:24.084Z

http://purl.org/np/RAUYWltYQF... RAUYWltYQF

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Leoni Bücken

2021-07-03T13:57:24.084Z

http://purl.org/np/RAUYWltYQF... RAUYWltYQF

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

Leoni Bücken

2021-07-03T13:57:24.084Z

http://purl.org/np/RAUYWltYQF... RAUYWltYQF

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://schema.org/TreatmentIndication TreatmentIndication

Leoni Bücken

2021-07-03T13:57:24.084Z